Acorda Therapeutics
ACOR
#10421
Rank
NZ$1.47 M
Marketcap
$1.19
Share price
0.00%
Change (1 day)
-95.28%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): -$17.60

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -$17.62. In 2022 the company made an earnings per share (EPS) of -$158.97 an increase over its 2021 EPS that were of -$359.76.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$17.60-88.93%
2022-$158.97-55.81%
2021-$359.76-16.13%
2020-$428.97-65.51%
2019-$1,244-898.61%
2018$155.73-114.88%
2017-$1,047536.84%
2016-$164.38-392.31%
2015$56.23-39.53%
2014$93.004.88%
2013$88.68-89.54%
2012$847.85409.09%
2011$166.54-333.33%
2010-$71.37-85.14%
2009-$480.161.37%
2008-$473.6751.03%
2007-$313.62-68.27%
2006-$988.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.77-121.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.40-107.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.42-91.92%๐Ÿ‡ฉ๐Ÿ‡ช Germany
-$14.11-19.92%๐Ÿ‡บ๐Ÿ‡ธ USA